Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Trelegy

- PMLiVE

Rigel on the slide as asthma drug falls over

Share plummet after phase II failure of R343

- PMLiVE

Video for neglected tropical diseases challenges viewers

Non-profit organisation END7 asks: 'Can you watch what they watched?'

- PMLiVE

Discount convinces NICE to uphold recommendation for Novartis’ Xolair

Asthma drug now also available for children

- PMLiVE

Merck & Co shares fall on Q4 results, osteoporosis drug delay

Sales down on loss of patent protection for Singulair

- PMLiVE

Olympic gold medalist becomes face of Asthma UK

Cyclist Laura Trott is supporting the charity’s Facebook page

Road wins UK asthma treatment brief

Virginia Medical Supplies to launch Salin Plus ventilator in the UK

- PMLiVE

NICE to reverse approval for Novartis’ asthma drug Xolair

Draft guidance doesn't recommend omalizumab for severe asthma

- PMLiVE

GSK takes severe asthma antibody into phase III

Mepolizumab could help patients who cannot prevent attacks using current therapies

- PMLiVE

COPD-asthma cases set to grow in Europe as people live longer

Study also highlights the respiratory burden the elderly will face

Problems at home can prevent children taking asthma drugs

Busy parents and financial problems could lead to poorer medicine adherence

- PMLiVE

European Commission wants tougher anti-smoking measures to halt spread of chronic diseases

Large number of young smokers will lead to further problems says EC's Martin Seychell at ERS congress

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links